Established in 2018 and with a registered capital of 80 million RMB, Shandong New Line Biotechnology Co., Ltd. (New Line) wis a scientific and technological enterprise focusing on the research and development, cultivation, production and sales of alternative and reduced resistance feed additive products. New Line has set up an innovation consortium with Jiangsu Academy of Agricultural Sciences. Exclusively supported by its International Phage R&D Center (IPRC), New Line has set up a scientific research team consisting of more than 30 PhDs and masters as the main backbone; Furthermore, New Line cooperates closely with Chinese Academy of Sciences and CTC Bio Inc. of South Korea, etc., to solve the problem of drug-resistant bacteria in a number of fields such as animal husbandry and agriculture by utilizing phage biological solutions to provide support for the prevention and control of bacterial infections.